Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that sy···【more】
Release date：2026-03-10Recommended：57
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors a···【more】
Release date：2026-03-09Recommended：70
The price of entrectinib fluctuates due to differences in specifications, purcha···【more】
Release date：2026-03-09Recommended：54
The price of entrectinib varies depending on factors such as region, medical ins···【more】
Release date：2026-03-09Recommended：72
Entrectinib is a targeted therapy for solid tumors positive for NTRK gene fusion···【more】
Release date：2026-03-09Recommended：63
Lucius Pharmaceuticals Osimertinib is a targeted therapy used to treat non-small···【more】
Release date：2026-03-06Recommended：58
The price of Osimertinib varies depending on specifications, region, and medical···【more】
Release date：2026-03-06Recommended：61
The price of osimertinib varies depending on specifications, region, purchasing ···【more】
Release date：2026-03-06Recommended：88
Osimertinib is a targeted therapy used to treat specific types of non-small cell···【more】
Release date：2026-03-06Recommended：83
Lorlatinib is a novel, third-generation, small-molecule dual ALK/ROS1 tyrosine k···【more】
Release date：2026-03-05Recommended：83
In September 2018, Lorlatinib was first approved for marketing in Japan, followe···【more】
Release date：2026-03-05Recommended：83
On October 12, 2023, Pfizer Inc. announced that the U.S. Food and Drug Administr···【more】
Release date：2026-03-05Recommended：77
